Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Cancer

Explore clinical trials studying Non-Small-Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

87 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Cancer trial results

Active, not recruiting

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT05355701

Conditions
Advanced Colorectal Cancer (Part 1), Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Clinical and Translational Research Center (CTRC) Aurora, Colorado, United States
  • UCHealth Sue Anschutz-Rodgers Eye Center Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) Aurora, Colorado, United States
View all 40 locations
View Trial Details
Active, not recruiting

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

NCT02609776

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Duarte, California, United States
  • La Jolla, California, United States
  • Orange, California, United States
  • Santa Monica, California, United States
View all 69 locations
View Trial Details
Active, not recruiting

Lorlatinib Continuation Study

NCT05144997

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • The First affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Active, not recruiting

Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

NCT06245837

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
  • Research Site Irkutsk, Russia
  • Research Site Kemerovo, Russia
View all 16 locations
View Trial Details
Active, not recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, not recruiting

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

NCT04547504

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU AMIENS - Hôpital Sud Amiens, France
  • Chu Angers Angers, France
  • CHRU de Brest Brest, France
View all 29 locations
View Trial Details
Completed

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

NCT04181788

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View all 49 locations
View Trial Details
Completed

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

NCT04768075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fujian, Fuzhou, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 14 locations
View Trial Details

Related conditions